Moreover, an elevated type I IFNs signature has been observed in blood-derived macrophages and brain tissue of patients with C9-ALS/FTD, and this elevated signature can be suppressed with administration of a STING inhibitor [154]. The gene discussed is STING1; the disease is amyotrophic lateral sclerosis.